Charles Greenberg to Anticoagulants
This is a "connection" page, showing publications Charles Greenberg has written about Anticoagulants.
Connection Strength
1.009
-
Review article: heparin sensitivity and resistance: management during cardiopulmonary bypass. Anesth Analg. 2013 Jun; 116(6):1210-22.
Score: 0.367
-
Limited impact of clinician education on reducing inappropriate PF4 testing for heparin-induced thrombocytopenia. J Thromb Thrombolysis. 2019 Feb; 47(2):287-291.
Score: 0.139
-
Heparin-associated thrombocytopenia and thrombosis: implications for perioperative management. Anesthesiology. 1997 Sep; 87(3):667-75.
Score: 0.126
-
The use of novel oral anticoagulants for thromboprophylaxis after elective major orthopedic surgery. Expert Rev Hematol. 2013 Dec; 6(6):677-95.
Score: 0.097
-
Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosis. Thromb Haemost. 1992 Mar 02; 67(3):292-6.
Score: 0.086
-
Production of a novel anticoagulant by neoplastic plasma cells: report of a case and review of the literature. Am J Med. 1989 May; 86(5):612-6.
Score: 0.071
-
AGA Clinical Practice Update: Coagulation in Cirrhosis. Gastroenterology. 2019 07; 157(1):34-43.e1.
Score: 0.035
-
Standardization of prothrombin fragment 1.2 measurement: effects of preanalytical variables and calibrator selection. Arch Pathol Lab Med. 1998 Jan; 122(1):31-6.
Score: 0.032
-
Factor XII deficiency and cardiopulmonary bypass: use of a novel modification of the activated clotting time to monitor anticoagulation. Anesthesiology. 1997 Oct; 87(4):990-2.
Score: 0.032
-
Evaluation of preanalytical variables associated with measurement of prothrombin fragment 1.2. Clin Chem. 1994 Oct; 40(10):1962-9.
Score: 0.026